Tower Research Capital LLC (Trc) Hillstream Bio Pharma Inc. Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.19 - $0.42 $311 - $688	1,640 Added 9.41%	19,067 $3,000
Q2 2023 Aug 14, 2023	BUY	$0.34 - $1.09 $1,903 - $6,102	5,599 Added 47.34%	17,427 $6,000
Q1 2023 May 09, 2023	BUY	$0.34 - $1.89 $944 - $5,250	2,778 Added 30.7%	11,828 $9,000
Q4 2022 Feb 10, 2023	BUY	$0.32 - $0.61 $166 - $316	519 Added 6.08%	9,050 $4,000
Q3 2022 Nov 10, 2022	BUY	$0.78 - $1.48 $3,062 - $5,810	3,926 Added 85.26%	8,531 $7,000
Q2 2022 Aug 15, 2022	SELL	$0.67 - $1.51 $2,349 - $5,294	-3,506 Reduced 43.23%	4,605 $4,000
Q1 2022 May 12, 2022	BUY	$1.16 - $4.1 $9,408 - $33,255	8,111 New	8,111 $13,000

Ticker HILS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,529,900
Market Cap $33.2M
Description
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.